Browse by Journal Title

Article

Genetic characterization of primary mediastinal B-cell lymphoma: pathogenesis and patient outcomes.
Noerenberg, D. and Briest, F. and Hennch, C. and Yoshida, K. and Hablesreiter, R. and Takeuchi, Y. and Ueno, H. and Staiger, A.M. and Ziepert, M. and Asmar, F. and Locher, B.N. and Toth, E. and Weber, T. and Amini, R.M. and Klapper, W. and Bouzani, M. and Poeschel, V. and Rosenwald, A. and Held, G. and Campo, E. and Ishaque, N. and Stamatopoulos, K. and Kanellis, G. and Anagnostopoulos, I. and Bullinger, L. and Goldschmidt, N. and Zinzani, P.L. and Bödör, C. and Rosenquist, R. and Vassilakopoulos, T.P. and Ott, G. and Ogawa, S. and Damm, F.
Journal of Clinical Oncology 42 (4): 452-466. 1 February 2024

Consensus molecular subtypes as biomarkers of fluorouracil and folinic acid maintenance therapy with or without panitumumab in (RAS) wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212).
Stahler, A. and Hoppe, B. and Na, I.K. and Keilholz, L. and Müller, L. and Karthaus, M. and Fruehauf, S. and Graeven, U. and Fischer von Weikersthal, L. and Goekkurt, E. and Kasper, S. and Kind, A.J. and Kurreck, A. and Alig, A.H.S. and Held, S. and Reinacher-Schick, A. and Heinemann, V. and Horst, D. and Jarosch, A. and Stintzing, S. and Trarbach, T. and Modest, D.P.
Journal of Clinical Oncology 41 (16): 2975-2987. 1 June 2023

Nivolumab and doxorubicin, vinblastine, and dacarbazine in early-stage unfavorable Hodgkin Lymphoma: final analysis of the randomized german Hodgkin study group phase II NIVAHL trial.
Bröckelmann, P.J. and Bühnen, I. and Meissner, J. and Trautmann-Grill, K. and Herhaus, P. and Halbsguth, T.V. and Schaub, V. and Kerkhoff, A. and Mathas, S. and Bormann, M. and Dickhut, A. and Kaul, H. and Fuchs, M. and Kobe, C. and Baues, C. and Borchmann, P. and Engert, A. and von Tresckow, B.
Journal of Clinical Oncology 41 (6): 1193-1199. 20 February 2023

Role of donor clonal hematopoiesis in allogeneic hematopoietic stem-cell transplantation.
Frick, M. and Chan, W. and Arends, C.M. and Hablesreiter, R. and Halik, A. and Heuser, M. and Michonneau, D. and Blau, O. and Hoyer, K. and Christen, F. and Galan-Sousa, J. and Noerenberg, D. and Wais, V. and Stadler, M. and Yoshida, K. and Schetelig, J. and Schuler, E. and Thol, F. and Clappier, E. and Christopeit, M. and Ayuk, F. and Bornhäuser, M. and Blau, I.W. and Ogawa, S. and Zemojtel, T. and Gerbitz, A. and Wagner, E.M. and Spriewald, B.M. and Schrezenmeier, H. and Kuchenbauer, F. and Kobbe, G. and Wiesneth, M. and Koldehoff, M. and Socié, G. and Kroeger, N. and Bullinger, L. and Thiede, C. and Damm, F.
Journal of Clinical Oncology 37 (5): 375-385. 10 February 2019

Phase II trial of temsirolimus for relapsed/refractory primary CNS lymphoma.
Korfel, A. and Schlegel, U. and Herrlinger, U. and Dreyling, M. and Schmidt, C. and von Baumgarten, L. and Pezzutto, A. and Grobosch, T. and Kebir, S. and Thiel, E. and Martus, P. and Kiewe, P.
Journal of Clinical Oncology 34 (15): 1757-1763. 20 May 2016

Efficacy of prophylactic low-molecular weight heparin for ambulatory patients with advanced pancreatic cancer: outcomes from the CONKO-004 trial.
Pelzer, U. and Opitz, B. and Deutschinoff, G. and Stauch, M. and Reitzig, P.C. and Hahnfeld, S. and Mueller, L. and Grunewald, M. and Stieler, J.M. and Sinn, M. and Denecke, T. and Bischoff, S. and Oettle, H. and Doerken, B. and Riess, H.
Journal of Clinical Oncology 33 (18): 2028-2034. 20 June 2015

Second-line oxaliplatin, folinic acid, and fluorouracil versus folinic acid and fluorouracil alone for gemcitabine-refractory pancreatic cancer : outcomes from the CONKO-003 trial.
Oettle, H. and Riess, H. and Stieler, J.M. and Heil, G. and Schwaner, I. and Seraphin, J. and Goerner, M. and Moelle, M. and Greten, T.F. and Lakner, V. and Bischoff, S. and Sinn, M. and Doerken, B. and Pelzer, U.
Journal of Clinical Oncology 32 (23): 2423-2429. 10 August 2014

(90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial.
Scholz, C.W. and Pinto, A. and Linkesch, W. and Lindén, O. and Viardot, A. and Keller, U. and Hess, G. and Lastoria, S. and Lerch, K. and Frigeri, F. and Arcamone, M. and Stroux, A. and Frericks, B. and Pott, C. and Pezzutto, A.
Journal of Clinical Oncology 31 (3): 308-313. 20 January 2013

Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage Hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin study group.
Borchmann, P. and Haverkamp, H. and Diehl, V. and Cerny, T. and Markova, J. and Ho, A.D. and Eich, H.T. and Mueller-Hermelink, H.K. and Kanz, L. and Greil, R. and Rank, A. and Paulus, U. and Smardova, L. and Huber, C. and Doerken, B. and Nerl, C. and Krause, S.W. and Mueller, R.P. and Fuchs, M. and Engert, A.
Journal of Clinical Oncology 29 (32): 4234-4342. 10 November 2011

Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954.
Schuhmacher, C. and Gretschel, S. and Lordick, F. and Reichardt, P. and Hohenberger, W. and Eisenberger, C.F. and Haag, C. and Mauer, M.E. and Hasan, B. and Welch, J. and Ott, K. and Hoelscher, A. and Schneider, P.M. and Bechstein, W. and Wilke, H. and Lutz, M.P. and Nordlinger, B. and Van Cutsem, E. and Siewert, J.R. and Schlag, P.M.
Journal of Clinical Oncology 28 (35): 5210-5218. 10 December 2010

Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.
Eich, H.T. and Diehl, V. and Goergens, H. and Pabst, T. and Markova, J. and Debus, J. and Ho, A. and Doerken, B. and Rank, A. and Grosu, A.L. and Wiegel, T. and Karstens, J.H. and Greil, R. and Willich, N. and Schmidberger, H. and Doehner, H. and Borchmann, P. and Mueller-Hermelink, H.K. and Mueller, R.P. and Engert, A.
Journal of Clinical Oncology 28 (27): 4199-4206. 20 September 2010

Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
Engert, A. and Diehl, V. and Franklin, J. and Lohri, A. and Doerken, B. and Ludwig, W.D. and Koch, P. and Haenel, M. and Pfreundschuh, M. and Wilhelm, M. and Truemper, L. and Aulitzky, W.E. and Bentz, M. and Rummel, M. and Sezer, O. and Mueller-Hermelink, H.K. and Hasenclever, D. and Loeffler, M.
Journal of Clinical Oncology 27 (27): 4548-4554. 20 September 2009

Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer.
Ghadjar, P. and Coupland, S.E. and Na, I.K. and Noutsias, M. and Letsch, A. and Stroux, A. and Bauer, S. and Buhr, H.J. and Thiel, E. and Scheibenbogen, C. and Keilholz, U.
Journal of Clinical Oncology 24 (12): 1910-1916. 20 April 2006

Vascular endothelial growth factor-D and its receptor VEGFR-3: Two novel independent prognostic markers in gastric adenocarcinoma.
Juettner, S. and Wissmann, C. and Joens, T. and Vieth, M. and Hertel, J. and Gretschel, S. and Schlag, P.M. and Kemmner, W. and Hoecker, M.
Journal of Clinical Oncology 24 (2): 228-240. 10 January 2006

Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: a randomized phase II study.
Thuss-Patience, P.C. and Kretzschmar, A. and Repp, M. and Kingreen, D. and Hennesser, D. and Micheel, S. and Pink, D. and Scholz, C. and Doerken, B. and Reichardt, P.
Journal of Clinical Oncology 23 : 494-501. 1 January 2005

6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
Buechner, T. and Hiddemann, W. and Berdel, W.E. and Woermann, B. and Schoch, C. and Fonatsch, C. and Loeffler, H. and Haferlach, T. and Ludwig, W.D. and Maschmeyer, G. and Staib, P. and Aul, C. and Grueneisen, A. and Lengfelder, E. and Frickhofen, N. and Kern, W. and Serve, H.L. and Mesters, R.M. and Sauerland, M.C. and Heinecke, A.
Journal of Clinical Oncology 21 : 4496-4504. 15 December 2003

Dynamic expression profile of p21 WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy.
Rau, B. and Sturm, I. and Lage, H. and Berger, S. and Schneider, U. and Haupfmann, S. and Wust, P. and Riess, H. and Schlag, P.M. and Doerken, B. and Daniel, P.T.
Journal of Clinical Oncology 21 (18): 3391-3401. 15 September 2003

Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
Haferlach, T. and Schoch, C. and Loeffler, H. and Gassmann, W. and Kern, W. and Schnittger, S. and Fonatsch, C. and Ludwig, W.D. and Wuchter, C. and Schlegelberger, B. and Staib, P. and Reichle, A. and Kubica, U. and Eimermacher, H. and Balleisen, L. and Grueneisen, A. and Haase, D. and Aul, C. and Karow, J. and Lengfelder, E. and Woermann, B. and Heinecke, A. and Sauerland, M.C. and Buechner, T. and Hiddemann, W.
Journal of Clinical Oncology 21 : 256-265. 15 January 2003

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.
Lakhani, S.R. and Van de Vijver, M.J. and Jacquemier, J. and Anderson, T.J. and Osin, P.P. and McGuffog, L. and Easton, D.F. and Scherneck, S. and Seitz, S.
Journal of Clinical Oncology 20 (9): 2310-2318. 1 May 2002

Expression of multidrug resistance genes MVP, MDR1, and MRP1 determined sequentially before, during, and after hyperthermic isolated limb perfusion of soft tissue sarcoma and melanoma patients.
Stein, U. and Juerchott, K. and Schlafke, M. and Hohenberger, P.
Journal of Clinical Oncology 20 (15): 3282-3292. 1 January 2002

Analysis of p53/BAX/p16(ink4a/CDKN2) in esophageal squamous cell carcinoma: High BAX and p16(nk4a/CDKN2) identifies patients with good prognosis.
Sturm, I. and Petrowsky, H. and Volz, R. and Lorenz, M. and Radetzki, S. and Hillebrand, T. and Wolff, G. and Hauptmann, S. and Doerken, B. and Daniel, P.T.
Journal of Clinical Oncology 19 : 2272-2281. 1 January 2001

Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases.
Sturm, I. and Koehne, C.H. and Wolff, G. and Petrowsky, H. and Hillebrand, T. and Hauptmann, S. and Lorenz, M. and Doerken, B. and Daniel, P.T.
Journal of Clinical Oncology 17 : 1364-1374. 1 May 1999

Dose-intensive chemotherapy with ifosfamide, epirubicin, and filgrastim for adult patients with metastatic or locally advanced soft tissue sarcoma: A phase II study.
Reichardt, P. and Tilgner, J. and Hohenberger, P. and Doerken, B.
Journal of Clinical Oncology 16 (4): 1438-1443. April 1998

Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer.
Koehne, C.H. and Schoeffski, P. and Wilke, H. and Kaeufer, C. and Andreesen, R. and Ohl, U. and Klaasen, U. and Westerhausen, M. and Hiddemann, W. and Schott, G. and Harstick, A. and Bade, J. and Horster, A. and Schubert, U. and Hecker, H. and Doerken, B. and Schmoll, H.J.
Journal of Clinical Oncology 16 (2): 418-426. February 1998

Role of cranial radiotherapy for childhood T-cell acute lymphobalstic leukemia with high WBC count and good response to prednisone.
Conter, V. and Schrappe, M. and Arico, M. and Reiter, A. and Rizzari, C. and Doerdelmann, M. and Valsecchi, M.G. and Zimmermann, M. and Ludwig, W.D. and Basso, G. and Masera, G. and Riehm, H.
Journal of Clinical Oncology 15 (8): 2786-2791. August 1997

Treatment of brain metastases in patients with testicular cancer.
Bokemeyer, C. and Nowak, P. and Haupt, A. and Metzner, B. and Koehne, H. and Hartmann, J.T. and Kanz, L. and Schmoll, H.J.
Journal of Clinical Oncology 15 (4): 1449-1454. April 1997

Failure of orally administered dipyridamole to enhance the antineoplastic activity of fluorouracil in combination with leucovorin in patients with advanced colorectal cancer: a prospective randomized trial.
Koehne, C.H. and Hiddemann, W. and Schueller, J. and Weiss, J. and Lohrmann, H.P. and Schmitz-Huebner, U. and Bodenstein, H. and Schoeber, C. and Wilke, H. and Grem, J. and Schmoll, H.J.
Journal of Clinical Oncology 13 : 1201-1208. 1 January 1995

Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Muenster Group.
Reiter, A. and Schrappe, M. and Parwaresch, R. and Henze, G. and Mueller-Weihrich, S. and Sauter, S. and Sykora, K.W. and Ludwig, W.D. and Gadner, H. and Riehm, H.
Journal of Clinical Oncology 13 : 359-372. 1 January 1995

Review

Genomics of acute myeloid leukemia diagnosis and pathways.
Bullinger, L. and Döhner, K. and Döhner, H.
Journal of Clinical Oncology 35 (9): 934-946. 20 March 2017

How to manage the obese patient with cancer.
Renehan, A.G. and Harvie, M. and Cutress, R.I. and Leitzmann, M. and Pischon, T. and Howell, S. and Howell, A.
Journal of Clinical Oncology 34 (35): 4284-4294. 10 December 2016

Pathogenesis of non-Hodgkin's lymphoma.
Nogai, H. and Doerken, B. and Lenz, G.
Journal of Clinical Oncology 29 (14): 1803-1811. 10 May 2011

Letter

Extravasations of oxaliplatin.
Kretzschmar, A. and Pink, D. and Thuss-Patience, P. and Doerken, B. and Reichert, P. and Eckert, R.
Journal of Clinical Oncology 21 (21): 4068-4069. 1 November 2003

Acute hypokalemic tetraparesis induced by intravenous methotrexate.
Thuss-Patience, P.C. and Peters, U. and Jurkat-Rott, K. and Pink, D. and Kretzschmar, A. and Doerken, B. and Reichardt, P.
Journal of Clinical Oncology 21 (9): 1896-1897. 1 May 2003